Clinical trials
Phase 1 Digestive System Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Unknown status | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Revolution Medicines, Inc. | 2 |
| Alnylam Pharmaceuticals | 1 |
| Celgene | 1 |
| Children's Hospital Los Angeles | 1 |
| Conatus Pharmaceuticals Inc. | 1 |
| Danielle Kim Turgeon | 1 |
| Gilead Sciences | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| IDRX, Inc., a wholly owned subsidiary of GSK, LLC | 1 |
| Indiana University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Digestive System Diseases | 16 |
| Digestive System Neoplasms | 5 |
| Gastrointestinal Diseases | 5 |
| Gastrointestinal Neoplasms | 5 |
| Neoplasms | 5 |
| Neoplasms by Site | 5 |
| Liver Diseases | 4 |
| Neoplasms, Glandular and Epithelial | 3 |
| Bronchial Neoplasms | 2 |
| Carcinoma, Bronchogenic | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.